Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery
Status:
Withdrawn
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Everolimus may stop the growth of tumor cells by blocking some of the enzymes
needed for cell growth and by blocking blood flow to the tumor.
PURPOSE: This phase II trial is studying how well everolimus works in treating women with
breast cancer that can be removed by surgery.